Standout Papers
Citation Impact
Citing Papers
A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling
2007 StandoutNobel
Loss of Hypoxia-Inducible Factor Prolyl Hydroxylase Activity in Cardiomyocytes Phenocopies Ischemic Cardiomyopathy
2010 StandoutNobel
Oral Torsemide in Patients With Chronic Congestive Heart Failure: Effects on Body Weight, Edema, and Electrolyte Excretion
1994
The prevention of heart failure in minority communities and discrepancies in health care delivery systems
2004
Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy
2001 StandoutNobel
Effects of captopril on survival in patients with heart failure
1988
Long-Term Trends in the Incidence of and Survival with Heart Failure
2002 Standout
Guidelines for the diagnosis and treatment of chronic heart failure
2001
Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations
2003
Treatment guidelines in heart failure
1998
EFFECT OF INTRAVENOUS NITRATES ON MORTALITY IN ACUTE MYOCARDIAL INFARCTION: AN OVERVIEW OF THE RANDOMISED TRIALS
1988
The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
1996 Standout
Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction
1992 Standout
Optimizing therapy for complex or refractory heart failure: A management algorithm
1998
Long-term oral nitrate therapy prevents chronic ventricular remodeling in the dog
1993
Prognosis of congestive heart failure and predictors of mortality
1988
Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure
1995
Wound repair and regeneration
2008 StandoutNature
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>
2003 Standout
Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated Cardiomyopathy
2004
The development of positive inotropic agents for chronic heart failure: How have we gone astray?
1993
Continuous home ambulatory intravenous inotropic drug therapy in severe heart failure: Safety and cost efficacy
1997
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
β-adrenergic blockade in chronic heart failure: Principles, progress, and practice
1998
Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation
2004 StandoutNobel
The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure
2005 Standout
Factors determining angiotensin‐converting enzyme inhibitor underutilization in heart failure in a community setting
1998
Clinical definition and epidemiology of advanced heart failure
1998
Effect of Oral Milrinone on Mortality in Severe Chronic Heart Failure
1991 Standout
Cost-effectiveness Analysis in Clinical Practice
1999
Update on recent clinical trials in congestive heart failure
2000
Lisinopril in the Treatment of Congestive Heart Failure in Elderly Patients: Comparison versus Captopril
1997
The epidemiology of heart failure: The Framingham Study
1993 Standout
Mechanisms of nitrate tolerance
1994
Valsartan benefits left ventricular structure and function in heart failure: Val-HeFT echocardiographic study
2002
Combination of Isosorbide Dinitrate and Hydralazine in Blacks with Heart Failure
2004
Successes and failures of current treatment of heart failure
1998
Effectiveness of imazodan for treatment of chronic congestive heart failure
1991
Predictors of total mortality and sudden death in mild to moderate heart failure
1989
Cardiac Resynchronization in Chronic Heart Failure
2002 Standout
Potentiation of beta-adrenergic signaling by adenoviral-mediated gene transfer in adult rabbit ventricular myocytes.
1997 StandoutNobel
Heart failure management: The impact of drug therapy on survival
1988
The Management of Chronic Heart Failure
1996
A Comparison of Enalapril with Hydralazine–Isosorbide Dinitrate in the Treatment of Chronic Congestive Heart Failure
1991 Standout
Management of heart failure. IV. Anticoagulation for patients with heart failure due to left ventricular systolic dysfunction
1994
Effect of phosphodiesterase inhibitors on survival of patients with chronic congestive heart failure
1989
Relation Between Gender, Etiology and Survival in Patients With Symptomatic Heart Failure
1996
Evolving trends in the epidemiologic factors of heart failure: Rationale for preventive strategies and comprehensive disease management
1997
Improving survival for patients with advanced heart failure: A study of 737 consecutive patients
1995
Short- and long-acting angiotensin-converting enzyme inhibitors: A randomized trial of lisinopril versus captopril in the treatment of congestive heart failure
1989
Practical recommendations for prehospital and early in-hospital management of patients presenting with acute heart failure syndromes
2008
Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs
2000 Standout
Heart failure
2005
Lesser Response to Angiotensin-Converting–Enzyme Inhibitor Therapy in Black as Compared with White Patients with Left Ventricular Dysfunction
2001
Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction
2001
Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemicdilated cardiomyopathy and asymptomaticnonsustained ventricular tachycardia—AMIOVIRT
2003
Prevalence and Incidence of Arrhythmias and Sudden Death in Heart Failure
2002
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
2013 Standout
Control of Myocardial Contractile Function by the Level of β-Adrenergic Receptor Kinase 1 in Gene-targeted Mice
1998 StandoutNobel
Decreased spontaneous heart rate variability in congestive heart failure
1989
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)
2005 Standout
Seven-transmembrane-spanning receptors and heart function
2002 StandoutNatureNobel
Congestive Heart Failure in the Community
1999
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
1999 Standout
Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
2006 Standout
Vasodilator and inotropic drugs for the treatment of chronic heart failure: Distinguishing hype from hope
1988
Prevalence and mortality rate of congestive heart failure in the United States
1992
Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction
2003 Standout
Heart failure in the 1990s: Evolutions of a major public health problem in cardiovascular medicine
1993
Beneficial effects of milrinone and enalapril on long-term survival of rats with healed myocardial infarction
1988
Predictors of prognosis in severe chronic heart failure
1992
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
2005 Standout
Calcium Channel Blockers in Heart Failure
1998
Bias in meta-analysis detected by a simple, graphical test
1997 Standout
Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling
2000 Standout
Linkage of β1-adrenergic stimulation to apoptotic heart cell death through protein kinase A–independent activation of Ca2+/calmodulin kinase II
2003 StandoutNobel
Racial differences in response to therapy for heart failure: Analysis of the vasodilator-heart failure trials
1999
Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure
2002 Standout
Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
1988 Standout
Dual modulation of cell survival and cell death by β 2 -adrenergic signaling in adult mouse cardiac myocytes
2001 StandoutNobel
Double-Blind, Placebo-Controlled Study of the Long-term Efficacy of Carvedilol in Patients With Severe Chronic Heart Failure
1995
Expression of a β-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice
1998 StandoutNobel
Enhancing quality of heart failure care in managed Medicare and Medicaid in North Carolina: Results of the North Carolina Achieving Cardiac Excellence (NC ACE) Project
2005
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
2017 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Chronic Heart Failure in the United States
1998
PROGNOSIS IN CONGESTIVE HEART FAILURE
1994
The Progression From Hypertension to Congestive Heart Failure
1996 Standout
Underlying Causes and Long-Term Survival in Patients with Initially Unexplained Cardiomyopathy
2000 Standout
Felodipine in patients with chronic heart failure: discrepant haemodynamic and clinical effects.
1987
Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Organic Nitrates in Patients With Chronic Heart Failure Treated With Angiotensin-Converting Enzyme Inhibition
1999
Evaluating Quality of Care for Patients With Heart Failure
2000
Studies of Left Ventricular Dysfunction (SOLVD)—Rationale, design and methods: Two trials that evaluate the effect of enalapril in patients with reduced ejection fraction
1990
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy
1987
Effect of the Calcium Antagonist Felodipine as Supplementary Vasodilator Therapy in Patients With Chronic Heart Failure Treated With Enalapril
1997
Comparative Effects of Therapy With Captopril and Digoxin in Patients With Mild to Moderate Heart Failure
1988
Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection Fractions
1992 Standout
Printed educational materials: effects on professional practice and healthcare outcomes
2012 Standout
Low Myocardial Protein Kinase G Activity in Heart Failure With Preserved Ejection Fraction
2012
Linkage of β1-adrenergic stimulation to apoptotic heart cell death through protein kinase A–independent activation of Ca2+/calmodulin kinase II
2003 StandoutNobel
Congestive Heart Failure in the Community
1998
Restoration of β-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer
1997 StandoutNobel
Acute Coronary Findings at Autopsy in Heart Failure Patients With Sudden Death
2000
Cardiac βARK1 inhibition prolongs survival and augments β blocker therapy in a mouse model of severe heart failure
2001 StandoutNobel
Reciprocal In Vivo Regulation of Myocardial G Protein–Coupled Receptor Kinase Expression by β-Adrenergic Receptor Stimulation and Blockade
1998 StandoutNobel
Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
2000 Standout
Relative Efficacy of Vasodilator Therapy in Chronic Congestive Heart Failure
1988
Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation
2004 StandoutNobel
Development and Prospective Validation of a Clinical Index to Predict Survival in Ambulatory Patients Referred for Cardiac Transplant Evaluation
1997
Heart Rate Variability
1996 Standout
Combination of isosorbide dinitrate and hydralazine in blacks with heart failure
2005
Catecholamines, Cardiac β-Adrenergic Receptors, and Heart Failure
2000 StandoutNobel
Medical Therapy Can Improve the Biological Properties of the Chronically Failing Heart
1996
Prospective, Randomized Comparison of Effect of Long-Term Treatment With Metoprolol or Carvedilol on Symptoms, Exercise, Ejection Fraction, and Oxidative Stress in Heart Failure
1999
Changes in hypertension treatment and in congestive heart failure mortality in the United States.
1989
Preservation of myocardial β-adrenergic receptor signaling delays the development of heart failure after myocardial infarction
2000 StandoutNobel
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
2018 Standout
Development of Congestive Heart Failure in Type 2 Diabetic Patients With Microalbuminuria or Proteinuria
2003
Complexity and contradiction in clinical trial research
1987
Works of Rob Saunders being referenced
Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure
1986 Standout
Effect of Short-Term Infusion of Sodium Nitroprusside on Mortality Rate in Acute Myocardial Infarction Complicated by Left Ventricular Failure
1982
Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure. Results of a Veterans Administration Cooperative Study
1987